BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17208294)

  • 1. High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor.
    Iyer AK; Greish K; Fang J; Murakami R; Maeda H
    Biomaterials; 2007 Apr; 28(10):1871-81. PubMed ID: 17208294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Styrene-maleic acid-copolymer conjugated zinc protoporphyrin as a candidate drug for tumor-targeted therapy and imaging.
    Fang J; Tsukigawa K; Liao L; Yin H; Eguchi K; Maeda H
    J Drug Target; 2016; 24(5):399-407. PubMed ID: 26302870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles.
    Nakamura H; Fang J; Gahininath B; Tsukigawa K; Maeda H
    J Control Release; 2011 Nov; 155(3):367-75. PubMed ID: 21600248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect.
    Fang J; Greish K; Qin H; Liao L; Nakamura H; Takeya M; Maeda H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):540-7. PubMed ID: 22576132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
    Greish K; Nagamitsu A; Fang J; Maeda H
    Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity.
    Sahoo SK; Sawa T; Fang J; Tanaka S; Miyamoto Y; Akaike T; Maeda H
    Bioconjug Chem; 2002; 13(5):1031-8. PubMed ID: 12236785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation.
    Iyer AK; Greish K; Seki T; Okazaki S; Fang J; Takeshita K; Maeda H
    J Drug Target; 2007; 15(7-8):496-506. PubMed ID: 17671896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor.
    Fang J; Sawa T; Akaike T; Akuta T; Sahoo SK; Khaled G; Hamada A; Maeda H
    Cancer Res; 2003 Jul; 63(13):3567-74. PubMed ID: 12839943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembly and emulsification of poly{[styrene-alt-maleic acid]-co-[styrene-alt-(N-3,4-dihydroxyphenylethyl-maleamic acid)]}.
    Chenglin Y; Yiqun Y; Ye Z; Na L; Xiaoya L; Jing L; Ming J
    Langmuir; 2012 Jun; 28(25):9211-22. PubMed ID: 22639900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
    Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
    Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model.
    Fujioka K; Kalish F; Wong RJ; Stevenson DK
    Pediatr Res; 2016 Feb; 79(2):251-7. PubMed ID: 26488552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting zinc protoporphyrin liposomes to the spleen using reticuloendothelial blockade with blank liposomes.
    Hamori CJ; Lasic DD; Vreman HJ; Stevenson DK
    Pediatr Res; 1993 Jul; 34(1):1-5. PubMed ID: 8356009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells.
    Herrmann H; Kneidinger M; Cerny-Reiterer S; Rülicke T; Willmann M; Gleixner KV; Blatt K; Hörmann G; Peter B; Samorapoompichit P; Pickl W; Bharate GY; Mayerhofer M; Sperr WR; Maeda H; Valent P
    Curr Cancer Drug Targets; 2012 Jan; 12(1):51-63. PubMed ID: 22165967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.
    Fang J; Sawa T; Akaike T; Greish K; Maeda H
    Int J Cancer; 2004 Mar; 109(1):1-8. PubMed ID: 14735461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
    Greish K; Sawa T; Fang J; Akaike T; Maeda H
    J Control Release; 2004 Jun; 97(2):219-30. PubMed ID: 15196749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-soluble polymer conjugates of ZnPP for photodynamic tumor therapy.
    Regehly M; Greish K; Rancan F; Maeda H; Böhm F; Röder B
    Bioconjug Chem; 2007; 18(2):494-9. PubMed ID: 17279724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc protoporphyrin polymeric nanoparticles: potent heme oxygenase inhibitor for cancer therapy.
    Rouhani H; Sepehri N; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
    Pharm Res; 2014 Aug; 31(8):2124-39. PubMed ID: 24558012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micelles of zinc protoporphyrin conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer for imaging and light-induced antitumor effects in vivo.
    Nakamura H; Liao L; Hitaka Y; Tsukigawa K; Subr V; Fang J; Ulbrich K; Maeda H
    J Control Release; 2013 Feb; 165(3):191-8. PubMed ID: 23220104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of light on metalloporphyrin-treated newborn mice.
    Wong RJ; Schulz S; Espadas C; Vreman HJ; Rajadas J; Stevenson DK
    Acta Paediatr; 2014 May; 103(5):474-9. PubMed ID: 24417721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease.
    Yin H; Fang J; Liao L; Nakamura H; Maeda H
    J Control Release; 2014 Aug; 187():14-21. PubMed ID: 24852097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.